Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipranavir in HIV/Hepatitis Co-infected Patients
NCT00447902Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Mar 2007; status: terminated.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00447902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447902.